Vivo Capital as of Dec. 31, 2016
Portfolio Holdings for Vivo Capital
Vivo Capital holds 25 positions in its portfolio as reported in the December 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Aclaris Therapeutics (ACRS) | 29.4 | $89M | 3.3M | 27.14 | |
| Ascendis Pharma A S (ASND) | 11.8 | $36M | 1.8M | 20.24 | |
| Codexis (CDXS) | 8.0 | $24M | 5.3M | 4.60 | |
| Nabriva Therapeutics | 7.9 | $24M | 4.0M | 5.96 | |
| Eiger Biopharmaceuticals | 6.9 | $21M | 1.8M | 11.65 | |
| Aimmune Therapeutics | 5.1 | $16M | 763k | 20.45 | |
| Advanced Accelerat spon ads each rep 2 ord | 4.0 | $12M | 456k | 26.76 | |
| Trevena | 3.4 | $10M | 1.7M | 5.88 | |
| Foamix Pharmaceuticals | 3.1 | $9.5M | 855k | 11.10 | |
| Regenxbio Inc equity us cm (RGNX) | 3.1 | $9.3M | 503k | 18.55 | |
| Agile Therapeutics | 2.8 | $8.6M | 1.5M | 5.70 | |
| Colucid Pharmaceuticals | 2.7 | $8.2M | 225k | 36.40 | |
| Strongbridge Bioph shs usd | 2.4 | $7.2M | 3.0M | 2.40 | |
| Capnia | 2.0 | $6.0M | 7.5M | 0.81 | |
| Biopharmx | 1.6 | $4.7M | 13M | 0.37 | |
| Akari Therapeutics | 1.2 | $3.7M | 528k | 7.04 | |
| Pronai Therapeutics | 1.2 | $3.6M | 2.4M | 1.49 | |
| Crispr Therapeutics (CRSP) | 1.0 | $3.0M | 149k | 20.26 | |
| Kalvista Pharmaceuticals (KALV) | 0.7 | $2.1M | 300k | 7.07 | |
| Sunesis Pharmaceuticals Inc Ne | 0.6 | $1.8M | 500k | 3.62 | |
| Revance Therapeutics (RVNC) | 0.5 | $1.6M | 77k | 20.70 | |
| Dynavax Technologies (DVAX) | 0.5 | $1.4M | 360k | 3.95 | |
| Ocera Therapeutics | 0.1 | $322k | 153k | 2.10 | |
| Zosano Pharma | 0.0 | $77k | 99k | 0.78 | |
| Capnia Inc Common Stock Warrants | 0.0 | $76k | 944k | 0.08 |
